Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-04-18

Clinical Trial Update: Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing half-dose depot triptorelin to reduced-dose daily buserelin in infertility has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triptorelin (triptorelin)
  • buserelin (buserelin)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Infertility | Phase 4 | Status: COMPLETED